JP2013521789A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013521789A5 JP2013521789A5 JP2012557522A JP2012557522A JP2013521789A5 JP 2013521789 A5 JP2013521789 A5 JP 2013521789A5 JP 2012557522 A JP2012557522 A JP 2012557522A JP 2012557522 A JP2012557522 A JP 2012557522A JP 2013521789 A5 JP2013521789 A5 JP 2013521789A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- antigen
- cell
- nucleic acid
- class
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31570410P | 2010-03-19 | 2010-03-19 | |
| GBGB1004551.6A GB201004551D0 (en) | 2010-03-19 | 2010-03-19 | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| US61/315,704 | 2010-03-19 | ||
| GB1004551.6 | 2010-03-19 | ||
| PCT/EP2011/053863 WO2011113819A2 (en) | 2010-03-19 | 2011-03-15 | Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015165375A Division JP6103608B2 (ja) | 2010-03-19 | 2015-08-25 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013521789A JP2013521789A (ja) | 2013-06-13 |
| JP2013521789A5 true JP2013521789A5 (enExample) | 2014-04-10 |
| JP5891181B2 JP5891181B2 (ja) | 2016-03-22 |
Family
ID=42227949
Family Applications (10)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012557522A Expired - Fee Related JP5891181B2 (ja) | 2010-03-19 | 2011-03-15 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2015165375A Expired - Fee Related JP6103608B2 (ja) | 2010-03-19 | 2015-08-25 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2016154278A Expired - Fee Related JP6238258B2 (ja) | 2010-03-19 | 2016-08-05 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2017030876A Active JP6535040B2 (ja) | 2010-03-19 | 2017-02-22 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2017224260A Active JP6722644B2 (ja) | 2010-03-19 | 2017-11-22 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2020106500A Expired - Fee Related JP7034505B2 (ja) | 2010-03-19 | 2020-06-19 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2020106497A Active JP7107586B2 (ja) | 2010-03-19 | 2020-06-19 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2021017733A Expired - Fee Related JP7007504B2 (ja) | 2010-03-19 | 2021-02-05 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2022108874A Pending JP2022141743A (ja) | 2010-03-19 | 2022-07-06 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2024095464A Pending JP2024116331A (ja) | 2010-03-19 | 2024-06-12 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
Family Applications After (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015165375A Expired - Fee Related JP6103608B2 (ja) | 2010-03-19 | 2015-08-25 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2016154278A Expired - Fee Related JP6238258B2 (ja) | 2010-03-19 | 2016-08-05 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2017030876A Active JP6535040B2 (ja) | 2010-03-19 | 2017-02-22 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2017224260A Active JP6722644B2 (ja) | 2010-03-19 | 2017-11-22 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2020106500A Expired - Fee Related JP7034505B2 (ja) | 2010-03-19 | 2020-06-19 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2020106497A Active JP7107586B2 (ja) | 2010-03-19 | 2020-06-19 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2021017733A Expired - Fee Related JP7007504B2 (ja) | 2010-03-19 | 2021-02-05 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2022108874A Pending JP2022141743A (ja) | 2010-03-19 | 2022-07-06 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
| JP2024095464A Pending JP2024116331A (ja) | 2010-03-19 | 2024-06-12 | 消化管癌および胃癌を含む数種の腫瘍に対する新規免疫療法 |
Country Status (30)
| Country | Link |
|---|---|
| US (25) | US10064913B2 (enExample) |
| EP (9) | EP3058947A3 (enExample) |
| JP (10) | JP5891181B2 (enExample) |
| KR (13) | KR20180014848A (enExample) |
| CN (8) | CN102905721B (enExample) |
| AU (1) | AU2011229199B2 (enExample) |
| BR (1) | BR112012023692B1 (enExample) |
| CA (5) | CA2789857C (enExample) |
| CY (5) | CY1119366T1 (enExample) |
| DK (6) | DK3195873T3 (enExample) |
| EA (8) | EA202091250A3 (enExample) |
| ES (8) | ES2993310T3 (enExample) |
| GB (1) | GB201004551D0 (enExample) |
| HK (1) | HK1226297A1 (enExample) |
| HR (6) | HRP20150867T1 (enExample) |
| HU (6) | HUE033682T2 (enExample) |
| LT (5) | LT3329933T (enExample) |
| ME (3) | ME03569B (enExample) |
| MX (7) | MX382164B (enExample) |
| MY (2) | MY178651A (enExample) |
| NZ (7) | NZ708205A (enExample) |
| PH (4) | PH12021551360A1 (enExample) |
| PL (6) | PL2547354T3 (enExample) |
| PT (6) | PT3363456T (enExample) |
| RS (6) | RS59554B1 (enExample) |
| SG (4) | SG10201502093QA (enExample) |
| SI (6) | SI3195873T1 (enExample) |
| TW (9) | TWI715332B (enExample) |
| UA (3) | UA111711C2 (enExample) |
| WO (1) | WO2011113819A2 (enExample) |
Families Citing this family (101)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7604662B2 (en) | 2007-07-13 | 2009-10-20 | Boston Scientific Scimed, Inc. | Endoprostheses containing boride intermetallic phases |
| EP2172211B1 (en) | 2008-10-01 | 2014-12-03 | Immatics Biotechnologies GmbH | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| GB201004551D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201004575D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| EP2400035A1 (en) * | 2010-06-28 | 2011-12-28 | Technische Universität München | Methods and compositions for diagnosing gastrointestinal stromal tumors |
| US9040046B2 (en) | 2011-01-31 | 2015-05-26 | Kai Xu | Sodium pump antibody agonists and methods of treating heart disease using the same |
| EP2771350B1 (en) | 2011-10-28 | 2018-01-10 | OncoTherapy Science, Inc. | Topk peptides and vaccines including the same |
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| EP2828664B1 (en) * | 2012-03-19 | 2018-09-26 | Stemline Therapeutics Inc. | Methods for treating and monitoring the status of cancer |
| CA2911191C (en) | 2012-05-16 | 2023-02-28 | Stemline Therapeutics, Inc. | Cancer stem cell targeted cancer vaccines |
| JP6255593B2 (ja) * | 2012-07-10 | 2018-01-10 | オンコセラピー・サイエンス株式会社 | Ｔｈ１細胞のＣＤＣＡ１エピトープペプチドおよびこれを含有するワクチン |
| US20150285802A1 (en) | 2012-07-18 | 2015-10-08 | Dana-Farber Cancer Institute, Inc. | Methods for treating, preventing and predicting risk of developing breast cancer |
| JP6212249B2 (ja) * | 2012-08-08 | 2017-10-11 | 学校法人 京都産業大学 | カルシウムポンプ制御物質のスクリーニング方法、並びに、メラニン色素合成阻害物質のスクリーニング方法 |
| WO2014035695A1 (en) * | 2012-08-30 | 2014-03-06 | The Board Of Trustees Of The Leland Stanford Junior University | Anti-tumor t cell immunity induced by high dose radiation |
| HRP20211852T1 (hr) | 2013-08-05 | 2022-03-18 | Immatics Biotechnologies Gmbh | Nova imunoterapija protiv nekoliko tumora, poput raka pluća, uključujući nsclc |
| TWI777195B (zh) * | 2013-08-05 | 2022-09-11 | 德商伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物（三） |
| EP2876442A1 (en) * | 2013-11-22 | 2015-05-27 | Institut de Cancérologie de l'Ouest | Olfactomedin-4, neudesin and desmoplakin as biomarkers of breast cancer |
| EP3092049A1 (en) | 2014-01-08 | 2016-11-16 | Flodesign Sonics Inc. | Acoustophoresis device with dual acoustophoretic chamber |
| AU2015222917A1 (en) | 2014-02-27 | 2016-09-15 | Lycera Corporation | Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods |
| WO2015164826A2 (en) * | 2014-04-24 | 2015-10-29 | Rhode Island Hospital | ASPARTATE-β-HYDROXYLASE INDUCES EPITOPE-SPECIFIC T CELL RESPONSES IN TUMORS |
| WO2015171558A2 (en) | 2014-05-05 | 2015-11-12 | Lycera Corporation | BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE |
| JP6728061B2 (ja) | 2014-05-05 | 2020-07-22 | リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ | ＲＯＲγアゴニストとして用いるテトラヒドロキノリンスルホンアミド及び関連化合物ならびに疾患の治療 |
| GB201408255D0 (en) * | 2014-05-09 | 2014-06-25 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML) |
| KR101644599B1 (ko) | 2014-10-14 | 2016-08-16 | 연세대학교 산학협력단 | 미토콘드리아 단백질 uqcrb 관련 질환 유전자발현 세포 구축 및 이를 활용한 uqcrb 기능조절 활성평가계 구축 |
| MA40737A (fr) * | 2014-11-21 | 2017-07-04 | Memorial Sloan Kettering Cancer Center | Déterminants de la réponse d'un cancer à une immunothérapie par blocage de pd-1 |
| GB201423361D0 (en) * | 2014-12-30 | 2015-02-11 | Immatics Biotechnologies Gmbh | Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides |
| US11304976B2 (en) | 2015-02-18 | 2022-04-19 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| KR20170117450A (ko) | 2015-02-18 | 2017-10-23 | 엔리벡스 테라퓨틱스 리미티드 | 암 치료를 위한 면역 요법 및 사이토카인 조절 요법의 조합 |
| WO2016170541A1 (en) | 2015-04-21 | 2016-10-27 | Enlivex Therapeutics Ltd. | Therapeutic pooled blood apoptotic cell preparations and uses thereof |
| US11318163B2 (en) | 2015-02-18 | 2022-05-03 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11000548B2 (en) | 2015-02-18 | 2021-05-11 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11596652B2 (en) | 2015-02-18 | 2023-03-07 | Enlivex Therapeutics R&D Ltd | Early apoptotic cells for use in treating sepsis |
| WO2017141243A1 (en) | 2016-02-18 | 2017-08-24 | Enlivex Therapeutics Ltd. | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11497767B2 (en) | 2015-02-18 | 2022-11-15 | Enlivex Therapeutics R&D Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| MY199500A (en) | 2015-03-17 | 2023-11-01 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers |
| GB201504502D0 (en) * | 2015-03-17 | 2015-04-29 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers |
| GB201507030D0 (en) * | 2015-04-24 | 2015-06-10 | Immatics Biotechnologies Gmbh | Immunotherapy against lung cancers, in particular NSCLC |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| EP3292119A4 (en) | 2015-05-05 | 2018-10-03 | Lycera Corporation | DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE |
| NL2014935B1 (en) | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| KR20180025894A (ko) | 2015-06-11 | 2018-03-09 | 라이세라 코퍼레이션 | Rory의 작용제로서 사용하기 위한 아릴 디히드로-2h-벤조[b][1,4]옥사진 술폰아미드 및 관련 화합물 및 질환의 치료 |
| GB201510771D0 (en) | 2015-06-19 | 2015-08-05 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer |
| IL292697A (en) * | 2015-06-19 | 2022-07-01 | Immatics Biotechnologies Gmbh | New peptides and their combination for use in immunotherapy and methods for creating supports for use against pancreatic cancer and other types of cancer |
| MA42294B1 (fr) | 2015-07-01 | 2020-11-30 | Immatics Biotechnologies Gmbh | Nouveaux peptides et combinaison de peptides à utiliser en immunothérapie contre le cancer de l'ovaire et d'autres cancers |
| GB201511546D0 (en) | 2015-07-01 | 2015-08-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| GB201512369D0 (en) * | 2015-07-15 | 2015-08-19 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers |
| US10335471B2 (en) * | 2015-08-28 | 2019-07-02 | Immatics Biotechnologies Gmbh | Method for treating cancer with activated T cells |
| TWI782434B (zh) | 2015-08-28 | 2022-11-01 | 德商英麥提克生物技術股份有限公司 | 用於多種癌症之免疫治療的新穎胜肽、胜肽的組合物及支架 |
| GB201515321D0 (en) | 2015-08-28 | 2015-10-14 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers |
| KR102601499B1 (ko) * | 2015-11-06 | 2023-11-13 | 연세대학교 산학협력단 | miRNA 발현 수준으로부터 UQCRB 관련 질병을 진단하는 방법 |
| GB201521746D0 (en) * | 2015-12-10 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers |
| EP4299136A3 (en) | 2015-12-16 | 2024-02-14 | Gritstone bio, Inc. | Neoantigen identification, manufacture, and use |
| IL302705A (en) * | 2016-03-01 | 2023-07-01 | Immatics Biotechnologies Gmbh | Peptides, combinations of peptides, cell-based drugs for use in immunotherapy against bladder cancer and other types of cancer |
| GB201603568D0 (en) * | 2016-03-01 | 2016-04-13 | Immatics Biotechnologies Gmbh | Efficient treatment options including peptides and combination of peptide and cell based medicaments for use in immunotherapy against urinary bladder cancer |
| GB201603987D0 (en) | 2016-03-08 | 2016-04-20 | Immatics Biotechnologies Gmbh | Uterine cancer treatments |
| GB201604490D0 (en) | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Peptides combination of peptides for use in immunotherapy against cancers |
| GB201604458D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against cancers |
| SG11201808629UA (en) | 2016-04-21 | 2018-11-29 | Immatics Biotechnologies Gmbh | Immunotherapy against melanoma and other cancers |
| SG10202006117QA (en) | 2016-04-21 | 2020-08-28 | Immatics Biotechnologies Gmbh | Immunotherapy against melanoma and other cancers |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| SI3500593T1 (sl) * | 2016-08-17 | 2021-12-31 | Immatics Biotechnologies Gmbh | T-celični receptorji in imunska terapija z njihovo uporabo |
| DE102016115246C5 (de) | 2016-08-17 | 2018-12-20 | Immatics Biotechnologies Gmbh | Neue t-zellrezeptoren und deren verwendung in immuntherapie |
| ZA201900664B (en) | 2016-08-17 | 2021-09-29 | Paul Ehrlich Strasse 15 Tuebingen 72076 Germany | T cell receptors and immune therapy using the same |
| CN109923121B (zh) | 2016-11-22 | 2022-12-23 | 武汉华大吉诺因生物科技有限公司 | 多肽及其应用 |
| CN110167956B (zh) * | 2016-11-30 | 2023-04-07 | 深圳华大生命科学研究院 | 多肽及其应用 |
| EP4317432A3 (en) | 2016-12-08 | 2024-04-17 | Immatics Biotechnologies GmbH | T cell receptors with improved pairing |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| US11427614B2 (en) | 2017-04-10 | 2022-08-30 | Immatics Biotechnologies Gmbh | Peptides and combination thereof for use in the immunotherapy against cancers |
| AU2018251839B2 (en) * | 2017-04-10 | 2022-06-30 | Immatics Biotechnologies Gmbh | Peptides and combination thereof for use in the immunotherapy against cancers |
| HUE054568T2 (hu) | 2017-07-14 | 2021-09-28 | Immatics Biotechnologies Gmbh | Továbbfejlesztett kettõs specificitású polipeptid molekula |
| DE102017115966A1 (de) | 2017-07-14 | 2019-01-17 | Immatics Biotechnologies Gmbh | Polypeptidmolekül mit verbesserter zweifacher Spezifität |
| EP3694532B1 (en) | 2017-10-10 | 2025-02-26 | Gritstone bio, Inc. | Neoantigen identification using hotspots |
| MX2020004741A (es) | 2017-11-06 | 2020-09-18 | Immatics Biotechnologies Gmbh | Nuevos receptores de las celulas t modificados geneticamente y terapias immunologicas que emplean los mismos. |
| DE102017125888A1 (de) * | 2017-11-06 | 2019-05-23 | Immatics Biotechnologies Gmbh | Neue konstruierte T-Zell-Rezeptoren und deren Verwendung in Immuntherapie |
| IL274799B2 (en) | 2017-11-22 | 2025-05-01 | Gritstone Bio Inc | Reducing junction epitope presentation for neoantigens |
| BR112020009889A2 (pt) | 2017-12-14 | 2020-11-03 | Flodesign Sonics, Inc. | acionador e controlador de transdutor acústico |
| JP2021517810A (ja) | 2018-03-12 | 2021-07-29 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ | 養子免疫療法における腫瘍自己抗原の使用のための方法および組成物 |
| US12195769B2 (en) | 2018-06-19 | 2025-01-14 | Dsm Ip Assets B.V. | Lipolytic enzyme variants |
| US20210380661A1 (en) * | 2018-10-16 | 2021-12-09 | Texas Tech University System | Method to Express, Purify, and Biotinylate Eukaryotic Cell-Derived Major Histocompatibility Complexes |
| EA202193139A1 (ru) | 2019-05-27 | 2022-03-01 | Имматикс Юс, Инк. | Вирусные векторы и их применение в адоптивной клеточной терапии |
| DE102019114735A1 (de) * | 2019-06-02 | 2020-12-03 | PMCR GmbH | HLA-Tumorantigenpeptiden der Klasse I und II zur Behandlung von Mamma-/Brustkarzinomen |
| MX2021015033A (es) | 2019-06-06 | 2022-01-18 | Immatics Biotechnologies Gmbh | Clasificacion con contraseleccion utilizando peptidos de secuencias similares. |
| KR102397922B1 (ko) * | 2020-02-19 | 2022-05-13 | 서울대학교 산학협력단 | 신규한 종양-관련 항원 단백질 olfm4 및 이의 용도 |
| WO2022045768A1 (ko) | 2020-08-28 | 2022-03-03 | 계명대학교 산학협력단 | 당뇨병 치료제에 대한 약물반응성 예측용 마이크로 rna 바이오마커 및 이의 용도 |
| WO2022109258A1 (en) * | 2020-11-19 | 2022-05-27 | Board Of Regents, The University Of Texas System | Methods and compositions comprising mhc class i peptides |
| DE102021100038A1 (de) | 2020-12-31 | 2022-06-30 | Immatics US, Inc. | Modifizierte cd8-polypeptide, zusammensetzungen und verfahren zu deren verwendung |
| WO2022147029A2 (en) | 2020-12-31 | 2022-07-07 | Immatics US, Inc. | Cd8 polypeptides, compositions, and methods of using thereof |
| BR112023022975A2 (pt) | 2021-05-05 | 2024-01-23 | Immatics Biotechnologies Gmbh | Polipeptídeos de ligação ao antígeno bma031 melhorados |
| CN114732898B (zh) * | 2022-04-01 | 2023-05-09 | 中国人民解放军军事科学院军事医学研究院 | 一种CpG佐剂与抗原定点共价结合方法 |
| EP4514821A1 (en) | 2022-04-28 | 2025-03-05 | Immatics US, Inc. | Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereof |
| WO2023212691A1 (en) | 2022-04-28 | 2023-11-02 | Immatics US, Inc. | DOMINANT NEGATIVE TGFβ RECEPTOR POLYPEPTIDES, CD8 POLYPEPTIDES, CELLS, COMPOSITIONS, AND METHODS OF USING THEREOF |
| KR20250018168A (ko) | 2022-04-28 | 2025-02-04 | 이매틱스 유에스 인코포레이티드 | 막-결합된 il-15, cd8 폴리펩티드, 세포, 조성물, 및 이의 사용 방법 |
| US20230355678A1 (en) | 2022-05-05 | 2023-11-09 | Immatics US, Inc. | Methods for improving t cell efficacy |
| WO2024072954A1 (en) * | 2022-09-29 | 2024-04-04 | Jerome Canady Research Institute for Advanced Biological and Technological Sciences | Cold atmopsheric plasma treated pan-cancer epitope peptide within the collagen type vi a-3 (col6a3) protein as cancer vaccine |
| WO2024077071A2 (en) * | 2022-10-05 | 2024-04-11 | The Johns Hopkins University | Nanoparticles for delivery of immunoregulatory materials to t cells |
| AU2024217580A1 (en) * | 2023-02-08 | 2025-07-31 | Navigen, Inc. | Tnf-alpha binding agents and methods of using the same |
| CN116102468B (zh) * | 2023-02-22 | 2024-07-09 | 中国科学技术大学 | 靶向人脂质运载蛋白2的先导化合物或其药学上可接受的盐及其制备方法与应用 |
| KR20240158819A (ko) * | 2023-04-26 | 2024-11-05 | 한국과학기술원 | 섬유아세포 활성화 단백질의 면역우세 에피토프 펩타이드 및 이의 용도 |
| US20250134931A1 (en) | 2023-11-01 | 2025-05-01 | Immatics US, Inc. | Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof |
| CN119679951A (zh) * | 2025-02-11 | 2025-03-25 | 安徽医科大学 | E3泛素连接酶syvn1的抑制物质在制备胃癌治疗药物中的应用 |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4440859A (en) | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| IN151589B (enExample) | 1978-12-22 | 1983-05-28 | Biogen Nv | |
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
| US4678751A (en) | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
| US4582800A (en) | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
| US4897445A (en) | 1986-06-27 | 1990-01-30 | The Administrators Of The Tulane Educational Fund | Method for synthesizing a peptide containing a non-peptide bond |
| AU6852594A (en) | 1993-06-03 | 1995-01-03 | Therapeutic Antibodies Inc. | Production of antibody fragments |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| WO1997026328A1 (en) | 1996-01-17 | 1997-07-24 | Imperial College Innovations Limited | Immunotherapy using cytotoxic t lymphocytes (ctl) |
| US5849589A (en) | 1996-03-11 | 1998-12-15 | Duke University | Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US8299321B2 (en) | 1998-06-16 | 2012-10-30 | Monsanto Technology Llc | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| WO2000018895A1 (en) * | 1998-09-25 | 2000-04-06 | The Children's Medical Center Corporation | Short peptides which selectively modulate the activity of protein kinases |
| AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
| CA2393738A1 (en) * | 1999-12-10 | 2001-06-14 | Epimmune Inc. | Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions |
| JP4310104B2 (ja) | 2002-09-28 | 2009-08-05 | 英俊 猪子 | マイクロサテライト遺伝多型マーカを用いる遺伝子のマッピング方法 |
| US20110131679A2 (en) | 2000-04-19 | 2011-06-02 | Thomas La Rosa | Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
| US20070067865A1 (en) | 2000-09-05 | 2007-03-22 | Kovalic David K | Annotated plant genes |
| EP1317275A1 (de) * | 2000-09-06 | 2003-06-11 | Müller, Friederike | Arzneimittel mit einer für das rna-bindende koc-protein kodierenden dna-sequenz, einem koc-protein oder einer dna-sequenz des koc-promotors |
| US20040110668A1 (en) | 2000-10-02 | 2004-06-10 | Burgess Christopher C. | Nucleic acid sequences differentially expressed in cancer tissue |
| US6673549B1 (en) * | 2000-10-12 | 2004-01-06 | Incyte Corporation | Genes expressed in C3A liver cell cultures treated with steroids |
| USH2191H1 (en) | 2000-10-24 | 2007-06-05 | Snp Consortium | Identification and mapping of single nucleotide polymorphisms in the human genome |
| WO2002036614A2 (en) | 2000-11-01 | 2002-05-10 | Insight Biotechnology Limited | Peptides for use in the treatment of alzheimer's disease |
| US7919467B2 (en) * | 2000-12-04 | 2011-04-05 | Immunotope, Inc. | Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| US20040236091A1 (en) * | 2001-03-28 | 2004-11-25 | Chicz Roman M. | Translational profiling |
| WO2002078516A2 (en) * | 2001-03-30 | 2002-10-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of cancer |
| US20040025202A1 (en) | 2002-03-15 | 2004-02-05 | Laurie Cathy C. | Nucleic acid molecules associated with oil in plants |
| DE10225139A1 (de) * | 2002-05-29 | 2004-02-26 | Immatics Biotechnologies Gmbh | Verfahren zur Identifizierung von immunreaktiven Peptiden |
| US20050221350A1 (en) * | 2002-05-29 | 2005-10-06 | Toni Weinschenk | Method for identifying immunoreactive peptides |
| WO2004014867A2 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| US20060188889A1 (en) * | 2003-11-04 | 2006-08-24 | Christopher Burgess | Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
| WO2005049806A2 (en) * | 2003-03-14 | 2005-06-02 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
| US20070037204A1 (en) * | 2003-08-08 | 2007-02-15 | Hiroyuki ABURANTAI | Gene overexpressed in cancer |
| WO2005019258A2 (en) * | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US20070054278A1 (en) | 2003-11-18 | 2007-03-08 | Applera Corporation | Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof |
| CA2554440A1 (en) * | 2004-01-27 | 2005-08-11 | Compugen Usa, Inc. | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| EP1568383A3 (en) | 2004-02-27 | 2005-11-16 | Antisense Pharma GmbH | Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment |
| US20070039069A1 (en) | 2004-03-22 | 2007-02-15 | Rogers James A | Nucleic acid molecules associated with oil in plants |
| ATE496142T1 (de) | 2004-03-23 | 2011-02-15 | Oncotherapy Science Inc | Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs |
| AT501014A1 (de) * | 2004-08-19 | 2006-05-15 | Kury & Zeillinger Oeg | Verfahren und kit zur diagnose einer krebserkrankung, verfahren zum feststellen des ansprechens eines patienten auf die behandlung einer krebserkrankung, therapeutikum zur prophylaxe oder behandlung einer krebserkrankung |
| WO2006023598A2 (en) * | 2004-08-19 | 2006-03-02 | University Of Maryland, Baltimore | Prostate-specific antigen-derived mhc class ii-restricted peptides and their use in vaccines to treat or prevent prostate cancer |
| WO2007005635A2 (en) * | 2005-07-01 | 2007-01-11 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Mitotic spindle protein aspm as a diagnostic marker for neoplasia and uses therefor |
| PT1760089E (pt) * | 2005-09-05 | 2009-10-19 | Immatics Biotechnologies Gmbh | Peptídeos associados a tumores que se ligam a moléculas de classe i ou ii do antigénio leucocitário humano (hla) e correspondente vacina anti-cancerígena |
| ATE461215T1 (de) * | 2005-09-05 | 2010-04-15 | Immatics Biotechnologies Gmbh | Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden |
| GB0521958D0 (en) | 2005-10-27 | 2005-12-07 | Ares Trading Sa | vWFA, collagen and kunitz domain containing protein |
| DE102005052384B4 (de) * | 2005-10-31 | 2009-09-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Erkennung, Markierung und Behandlung von epithelialen Lungentumorzellen sowie Mittel zur Durchführung des Verfahrens |
| US20080058272A1 (en) * | 2006-08-29 | 2008-03-06 | Juergen Becker | Nonamer Peptides for Cancer Treatment |
| US20090004213A1 (en) * | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| PL2562182T3 (pl) * | 2007-07-27 | 2016-03-31 | Immatics Biotechnologies Gmbh | Nowe immunogenne epitopy do immunoterapii |
| CA2694771A1 (en) * | 2007-07-27 | 2009-02-05 | Immatics Biotechnologies Gmbh | Composition of tumour-associated peptides and related anti-cancer vaccine |
| US7892770B2 (en) * | 2007-08-24 | 2011-02-22 | Van Andel Research Institute | Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods |
| NZ562237A (en) * | 2007-10-05 | 2011-02-25 | Pacific Edge Biotechnology Ltd | Proliferation signature and prognosis for gastrointestinal cancer |
| WO2009075883A2 (en) * | 2007-12-12 | 2009-06-18 | University Of Georgia Research Foundation, Inc. | Glycoprotein cancer biomarker |
| CN101648012A (zh) * | 2008-04-24 | 2010-02-17 | 伊玛提克斯生物技术有限公司 | 结合到人类白细胞抗原(hla)ⅰ类或ⅱ类分子上用作疫苗的肿瘤相关肽新制剂 |
| KR101184869B1 (ko) * | 2008-04-24 | 2012-09-20 | 이매틱스 바이오테크놀로지스 게엠베하 | 백신을 위한 인간 조직 적합성 항원(ｈｌａ) 종류 ｉ 또는 ｉｉ 분자에 결합하는 종양 관련 펩티드의 신규한 제형 |
| DE602008000891D1 (de) * | 2008-04-30 | 2010-05-12 | Immatics Biotechnologies Gmbh | Neuartige Formulierungen von Tumor-assoziierten Peptiden, welche an menschliche Leukozytenantigene der Klasse I oder II für Impfungen binden |
| US8133686B2 (en) * | 2008-05-15 | 2012-03-13 | Van Andel Research Institute | IL-8 as a biomarker for sunitinib resistance |
| TWI526219B (zh) * | 2008-06-19 | 2016-03-21 | 腫瘤療法 科學股份有限公司 | Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗 |
| US20110318380A1 (en) * | 2008-10-01 | 2011-12-29 | Dako Denmark A/S | MHC Multimers in Cancer Vaccines and Immune Monitoring |
| EP2172211B1 (en) | 2008-10-01 | 2014-12-03 | Immatics Biotechnologies GmbH | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| GB201004575D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201019331D0 (en) * | 2010-03-19 | 2010-12-29 | Immatics Biotechnologies Gmbh | Methods for the diagnosis and treatment of cancer based on AVL9 |
| GB201004551D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201006360D0 (en) * | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| GB201015765D0 (en) * | 2010-09-21 | 2010-10-27 | Immatics Biotechnologies Gmbh | Use of myeloid cell biomarkers for the diagnosis of cancer |
| GB201021289D0 (en) * | 2010-12-15 | 2011-01-26 | Immatics Biotechnologies Gmbh | Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer |
-
2010
- 2010-03-19 GB GBGB1004551.6A patent/GB201004551D0/en not_active Ceased
-
2011
- 2011-03-15 MX MX2017015735A patent/MX382164B/es unknown
- 2011-03-15 ES ES20179386T patent/ES2993310T3/es active Active
- 2011-03-15 EA EA202091250A patent/EA202091250A3/ru unknown
- 2011-03-15 NZ NZ708205A patent/NZ708205A/en not_active IP Right Cessation
- 2011-03-15 LT LTEP17203096.7T patent/LT3329933T/lt unknown
- 2011-03-15 PT PT181566340T patent/PT3363456T/pt unknown
- 2011-03-15 EP EP16156192.3A patent/EP3058947A3/en not_active Withdrawn
- 2011-03-15 ES ES20179380T patent/ES2992110T3/es active Active
- 2011-03-15 KR KR1020187002782A patent/KR20180014848A/ko not_active Ceased
- 2011-03-15 EA EA202091242A patent/EA202091242A3/ru unknown
- 2011-03-15 HU HUE15154344A patent/HUE033682T2/en unknown
- 2011-03-15 CA CA2789857A patent/CA2789857C/en active Active
- 2011-03-15 NZ NZ627877A patent/NZ627877A/en not_active IP Right Cessation
- 2011-03-15 SI SI201131804T patent/SI3195873T1/sl unknown
- 2011-03-15 EP EP15154344.4A patent/EP2923708B1/en active Active
- 2011-03-15 ES ES18156634T patent/ES2829375T3/es active Active
- 2011-03-15 KR KR1020227004088A patent/KR20220025133A/ko not_active Ceased
- 2011-03-15 UA UAA201209114A patent/UA111711C2/uk unknown
- 2011-03-15 AU AU2011229199A patent/AU2011229199B2/en not_active Ceased
- 2011-03-15 LT LTEP18156634.0T patent/LT3363456T/lt unknown
- 2011-03-15 KR KR1020207026530A patent/KR102324500B1/ko active Active
- 2011-03-15 ME MEP-2019-287A patent/ME03569B/me unknown
- 2011-03-15 ES ES14184348.2T patent/ES2626798T3/es active Active
- 2011-03-15 LT LT17157398T patent/LT3195873T/lt unknown
- 2011-03-15 KR KR1020197005246A patent/KR20190033577A/ko not_active Ceased
- 2011-03-15 HU HUE11711292A patent/HUE027036T2/en unknown
- 2011-03-15 BR BR112012023692A patent/BR112012023692B1/pt active IP Right Grant
- 2011-03-15 CN CN201180014644.0A patent/CN102905721B/zh active Active
- 2011-03-15 KR KR1020207026527A patent/KR102388761B1/ko active Active
- 2011-03-15 RS RS20191340A patent/RS59554B1/sr unknown
- 2011-03-15 CN CN201810105798.4A patent/CN108456242A/zh active Pending
- 2011-03-15 CA CA2986969A patent/CA2986969C/en active Active
- 2011-03-15 PL PL11711292T patent/PL2547354T3/pl unknown
- 2011-03-15 KR KR1020207026525A patent/KR102324498B1/ko not_active Expired - Fee Related
- 2011-03-15 RS RS20150530A patent/RS54182B1/sr unknown
- 2011-03-15 PH PH1/2021/551360A patent/PH12021551360A1/en unknown
- 2011-03-15 LT LTEP15154344.4T patent/LT2923708T/lt unknown
- 2011-03-15 HU HUE17157398A patent/HUE045757T2/hu unknown
- 2011-03-15 EA EA201690511A patent/EA039357B1/ru unknown
- 2011-03-15 PT PT117112920T patent/PT2547354E/pt unknown
- 2011-03-15 PL PL18156634T patent/PL3363456T3/pl unknown
- 2011-03-15 EP EP20179380.9A patent/EP3753570B1/en active Active
- 2011-03-15 NZ NZ769427A patent/NZ769427A/en not_active IP Right Cessation
- 2011-03-15 ES ES11711292.0T patent/ES2544529T3/es active Active
- 2011-03-15 NZ NZ769435A patent/NZ769435A/en not_active IP Right Cessation
- 2011-03-15 KR KR1020167023720A patent/KR101826460B1/ko active Active
- 2011-03-15 ES ES17203096T patent/ES2819861T3/es active Active
- 2011-03-15 PL PL17157398T patent/PL3195873T3/pl unknown
- 2011-03-15 PL PL14184348T patent/PL2845604T3/pl unknown
- 2011-03-15 PT PT151543444T patent/PT2923708T/pt unknown
- 2011-03-15 SI SI201131927T patent/SI3363456T1/sl unknown
- 2011-03-15 CA CA3206214A patent/CA3206214A1/en active Pending
- 2011-03-15 PT PT141843482T patent/PT2845604T/pt unknown
- 2011-03-15 SI SI201131182A patent/SI2845604T1/sl unknown
- 2011-03-15 DK DK17157398.3T patent/DK3195873T3/da active
- 2011-03-15 SI SI201130546T patent/SI2547354T1/sl unknown
- 2011-03-15 EP EP11711292.0A patent/EP2547354B1/en active Active
- 2011-03-15 LT LTEP14184348.2T patent/LT2845604T/lt unknown
- 2011-03-15 NZ NZ711296A patent/NZ711296A/en not_active IP Right Cessation
- 2011-03-15 RS RS20201054A patent/RS60765B1/sr unknown
- 2011-03-15 DK DK11711292.0T patent/DK2547354T3/da active
- 2011-03-15 ES ES17157398T patent/ES2753206T3/es active Active
- 2011-03-15 WO PCT/EP2011/053863 patent/WO2011113819A2/en not_active Ceased
- 2011-03-15 EA EA201201306A patent/EA024497B1/ru unknown
- 2011-03-15 DK DK17203096.7T patent/DK3329933T3/da active
- 2011-03-15 EP EP18156634.0A patent/EP3363456B1/en active Active
- 2011-03-15 EA EA202091233A patent/EA202091233A3/ru unknown
- 2011-03-15 EP EP20179386.6A patent/EP3738606B1/en active Active
- 2011-03-15 RS RS20170980A patent/RS56612B1/sr unknown
- 2011-03-15 KR KR1020217004318A patent/KR102329791B1/ko active Active
- 2011-03-15 DK DK15154344.4T patent/DK2923708T3/en active
- 2011-03-15 CA CA2936642A patent/CA2936642C/en active Active
- 2011-03-15 SG SG10201502093QA patent/SG10201502093QA/en unknown
- 2011-03-15 US US13/635,896 patent/US10064913B2/en active Active
- 2011-03-15 DK DK18156634.0T patent/DK3363456T3/da active
- 2011-03-15 CA CA3076642A patent/CA3076642C/en active Active
- 2011-03-15 KR KR1020207026532A patent/KR102324499B1/ko active Active
- 2011-03-15 RS RS20201304A patent/RS60993B1/sr unknown
- 2011-03-15 EP EP17157398.3A patent/EP3195873B1/en active Active
- 2011-03-15 SG SG2012065173A patent/SG183880A1/en unknown
- 2011-03-15 UA UAA201512437A patent/UA122047C2/uk unknown
- 2011-03-15 KR KR1020217004319A patent/KR102361467B1/ko not_active Expired - Fee Related
- 2011-03-15 ME MEP-2015-122A patent/ME02229B/me unknown
- 2011-03-15 MX MX2012010813A patent/MX2012010813A/es active IP Right Grant
- 2011-03-15 HR HRP20150867TT patent/HRP20150867T1/hr unknown
- 2011-03-15 DK DK14184348.2T patent/DK2845604T3/da active
- 2011-03-15 EP EP17203096.7A patent/EP3329933B1/en active Active
- 2011-03-15 SG SG10201710446PA patent/SG10201710446PA/en unknown
- 2011-03-15 HU HUE18156634A patent/HUE051478T2/hu unknown
- 2011-03-15 RS RS20170553A patent/RS56070B1/sr unknown
- 2011-03-15 ME MEP-2017-87A patent/ME02692B/me unknown
- 2011-03-15 CN CN202011079575.9A patent/CN112409452A/zh active Pending
- 2011-03-15 CN CN202011079539.2A patent/CN112409451B/zh active Active
- 2011-03-15 KR KR1020207026524A patent/KR102388577B1/ko active Active
- 2011-03-15 EA EA201792409A patent/EA037019B1/ru unknown
- 2011-03-15 NZ NZ601438A patent/NZ601438A/en not_active IP Right Cessation
- 2011-03-15 SI SI201131913T patent/SI3329933T1/sl unknown
- 2011-03-15 PT PT172030967T patent/PT3329933T/pt unknown
- 2011-03-15 NZ NZ72784111A patent/NZ727841A/en not_active IP Right Cessation
- 2011-03-15 EA EA202091241A patent/EA202091241A3/ru unknown
- 2011-03-15 KR KR1020237031847A patent/KR20230141886A/ko active Pending
- 2011-03-15 EP EP14184348.2A patent/EP2845604B1/en active Active
- 2011-03-15 SG SG10201606771SA patent/SG10201606771SA/en unknown
- 2011-03-15 JP JP2012557522A patent/JP5891181B2/ja not_active Expired - Fee Related
- 2011-03-15 HU HUE14184348A patent/HUE032402T2/en unknown
- 2011-03-15 CN CN201510354965.5A patent/CN105001339B/zh active Active
- 2011-03-15 ES ES15154344.4T patent/ES2642562T3/es active Active
- 2011-03-15 PL PL15154344T patent/PL2923708T3/pl unknown
- 2011-03-15 CN CN202011080378.9A patent/CN112409453A/zh active Pending
- 2011-03-15 PT PT171573983T patent/PT3195873T/pt unknown
- 2011-03-15 SI SI201131293T patent/SI2923708T1/sl unknown
- 2011-03-15 EA EA202091251A patent/EA202091251A3/ru unknown
- 2011-03-15 HU HUE17203096A patent/HUE050376T2/hu unknown
- 2011-03-15 PH PH1/2012/501821A patent/PH12012501821A1/en unknown
- 2011-03-15 MY MYPI2012700609A patent/MY178651A/en unknown
- 2011-03-15 CN CN202011080388.2A patent/CN112430255A/zh active Pending
- 2011-03-15 PL PL17203096T patent/PL3329933T3/pl unknown
- 2011-03-15 KR KR1020127027196A patent/KR101656913B1/ko active Active
- 2011-03-15 UA UAA201801266A patent/UA126787C2/uk unknown
- 2011-03-15 CN CN202011079527.XA patent/CN112457390A/zh active Pending
- 2011-03-18 TW TW108144354A patent/TWI715332B/zh not_active IP Right Cessation
- 2011-03-18 TW TW111118219A patent/TW202300509A/zh unknown
- 2011-03-18 TW TW107110964A patent/TWI681967B/zh not_active IP Right Cessation
- 2011-03-18 TW TW109130850A patent/TWI768461B/zh not_active IP Right Cessation
- 2011-03-18 TW TW104113109A patent/TWI621709B/zh active
- 2011-03-18 TW TW100109429A patent/TWI486445B/zh not_active IP Right Cessation
- 2011-03-18 TW TW106141450A patent/TWI659967B/zh not_active IP Right Cessation
- 2011-03-18 TW TW109130852A patent/TWI766362B/zh active
- 2011-03-18 TW TW109130851A patent/TWI766361B/zh not_active IP Right Cessation
- 2011-03-18 US US13/051,665 patent/US9101585B2/en active Active
-
2012
- 2012-09-06 MY MYPI2016002170A patent/MY197710A/en unknown
- 2012-09-19 MX MX2015001606A patent/MX355074B/es unknown
- 2012-09-19 MX MX2020011672A patent/MX2020011672A/es unknown
- 2012-09-19 MX MX2020011674A patent/MX2020011674A/es unknown
- 2012-09-19 MX MX2020011675A patent/MX2020011675A/es unknown
- 2012-09-19 MX MX2020011673A patent/MX2020011673A/es unknown
-
2013
- 2013-07-10 HK HK16114573.8A patent/HK1226297A1/en unknown
-
2015
- 2015-02-06 US US14/615,539 patent/US9717774B2/en active Active
- 2015-08-25 JP JP2015165375A patent/JP6103608B2/ja not_active Expired - Fee Related
-
2016
- 2016-05-23 PH PH12016500949A patent/PH12016500949B1/en unknown
- 2016-08-05 JP JP2016154278A patent/JP6238258B2/ja not_active Expired - Fee Related
-
2017
- 2017-02-22 JP JP2017030876A patent/JP6535040B2/ja active Active
- 2017-05-04 CY CY20171100486T patent/CY1119366T1/el unknown
- 2017-05-12 HR HRP20170718TT patent/HRP20170718T1/hr unknown
- 2017-06-28 US US15/636,486 patent/US20170304399A1/en not_active Abandoned
- 2017-06-29 US US15/636,958 patent/US9895415B2/en active Active
- 2017-06-30 US US15/639,506 patent/US10357540B2/en active Active
- 2017-06-30 US US15/639,310 patent/US9993523B2/en active Active
- 2017-10-06 HR HRP20171504TT patent/HRP20171504T1/hr unknown
- 2017-10-10 CY CY20171101050T patent/CY1119739T1/el unknown
- 2017-11-22 JP JP2017224260A patent/JP6722644B2/ja active Active
-
2019
- 2019-05-22 US US16/419,818 patent/US10420816B1/en active Active
- 2019-07-03 US US16/502,268 patent/US10478471B2/en active Active
- 2019-09-24 PH PH12019502194A patent/PH12019502194A1/en unknown
- 2019-10-14 HR HRP20191859TT patent/HRP20191859T1/hr unknown
- 2019-10-18 CY CY20191101092T patent/CY1122235T1/el unknown
- 2019-12-13 US US16/714,098 patent/US10905741B2/en not_active Expired - Fee Related
-
2020
- 2020-06-05 US US16/894,186 patent/US10898546B2/en active Active
- 2020-06-05 US US16/894,212 patent/US10933118B2/en active Active
- 2020-06-19 JP JP2020106500A patent/JP7034505B2/ja not_active Expired - Fee Related
- 2020-06-19 JP JP2020106497A patent/JP7107586B2/ja active Active
- 2020-09-14 HR HRP20201467TT patent/HRP20201467T1/hr unknown
- 2020-09-22 CY CY20201100894T patent/CY1123447T1/el unknown
- 2020-11-02 HR HRP20201770TT patent/HRP20201770T1/hr unknown
- 2020-11-04 CY CY20201101040T patent/CY1123762T1/el unknown
-
2021
- 2021-01-28 US US17/161,253 patent/US11077171B2/en active Active
- 2021-02-05 JP JP2021017733A patent/JP7007504B2/ja not_active Expired - Fee Related
- 2021-04-23 US US17/238,943 patent/US11850274B2/en active Active
- 2021-05-14 US US17/320,782 patent/US11883462B2/en active Active
- 2021-05-21 US US17/327,116 patent/US11839643B2/en active Active
- 2021-06-25 US US17/358,676 patent/US11969455B2/en active Active
- 2021-07-23 US US17/383,892 patent/US11975042B2/en active Active
- 2021-07-23 US US17/383,855 patent/US11957730B2/en active Active
- 2021-09-24 US US17/484,703 patent/US11273200B2/en active Active
- 2021-09-24 US US17/484,568 patent/US20220008506A1/en not_active Abandoned
- 2021-10-01 US US17/491,742 patent/US12064465B2/en active Active
- 2021-10-01 US US17/492,219 patent/US11298404B2/en active Active
-
2022
- 2022-04-29 US US17/733,260 patent/US11648292B2/en active Active
- 2022-07-06 JP JP2022108874A patent/JP2022141743A/ja active Pending
-
2024
- 2024-06-12 JP JP2024095464A patent/JP2024116331A/ja active Pending
- 2024-10-18 US US18/920,658 patent/US20250049886A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013521789A5 (enExample) | ||
| JP2010534463A5 (enExample) | ||
| HRP20170718T1 (hr) | Nova imunoterapija protiv nekoliko tumora uključujući gastrointestinalni i gastrični karcinom | |
| JP2009506762A5 (enExample) | ||
| JP2020182458A5 (enExample) | ||
| JP2018509135A5 (enExample) | ||
| JP2020198875A5 (enExample) | ||
| JP2020191862A5 (enExample) | ||
| JP2017525336A5 (enExample) | ||
| HRP20201228T1 (hr) | Nova imunoterapija protiv nekoliko tumora, uključujući tumore neurona i mozga | |
| HRP20100128T1 (hr) | Tumoru pridruženi peptid koji se slobodno veže na molekule humanog leukocitnog antigena (hla) klase ii | |
| RU2020113032A (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии рака легких, в том числе немелкоклеточного рака легких (нмрл) и других видов рака | |
| JP2018536383A5 (enExample) | ||
| JP2018532382A5 (enExample) | ||
| JP2019516663A5 (enExample) | ||
| HRP20192262T1 (hr) | Nova imunoterapija protiv nekoliko tumora, kao što su rak pluća, uključujući mikrocelularni karcinom pluća (nsclc) | |
| JP2017524337A5 (enExample) | ||
| JP2018511321A5 (enExample) | ||
| JP2019510465A5 (enExample) | ||
| JP2022189893A (ja) | トランスジェニックマクロファージ、キメラ抗原受容体、及び関連する方法 | |
| JP2018510628A5 (enExample) | ||
| JP2019536426A5 (enExample) | ||
| CN115443124A (zh) | 人工突触 | |
| KR20220103928A (ko) | 시험관 내 활성화 및 연쇄 살해 t 세포 집단의 확장 및 종양 세포 사멸 세포로 암 환자의 수동 면역화를 위한 조성물 및 방법 | |
| WO2023056193A2 (en) | Il-18 variants and uses thereof |